ASX Announcement

EMORY JOINS CHM CDH17 PHASE 1/2 CLINICAL TRIAL

Published: 24/04/25, 12:26pm (AEST)3 pages
Chimeric Therapeutics
CHM:ASXHealthcare

Recent CHM Announcements

Price Sensitive only